This proxy CRM platform is designed to promote consistent customer interaction on a global scale.

Pleasanton, California, USA, November 4, 2026 / PRNewswire / -- Veeva Systems ( NYSE : VEEV ) Today, we announce that UCB has chosen Veeva Vault CRM, an agent-based interactive platform designed for the life sciences industry. Vault CRM provides industry-specific artificial intelligence, aiming to accelerate product launch and create a better customer experience.

UCB Chief Digital Technology Officer Edwin Erckens stated: "We are delighted to further strengthen our strategic partnership with Veeva by migrating to Vault CRM. We both place great importance on customer success, and Vault CRM will provide the technical foundation necessary to drive commercialization for UCB."

President Chris Moore stated: " Vault CRM is a customer interaction platform that will provide a stable, scalable, and future-oriented technical foundation for UCB, helping to advance the business strategy of UCB. We will work together with UCB to support this critical effort."

Vault CRM is a part of Vault CRM Suite and also serves as the technical foundation for “Agentic Commercial”. Agentic Call Report within Vault CRM will generate “Commercial Evidence”, which aims to reveal previously undiscovered therapeutic obstacles.

About Veeva Systems

Veeva provides industry cloud solutions for the life sciences sector, covering applications, agency services, data management, and consulting services. Veeva is committed to innovation, product quality, and customer success, serving over 1500 clients ranging from the world's largest pharmaceutical companies to emerging biotech startups. As a public interest company, Veeva strives to balance the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, please visit veeva.com.

Veeva Forward-looking Statements

This press release contains forward-looking statements regarding Veeva products and services, as well as the expected results or benefits from using such products and services. These statements are based on the company's current expectations. Actual results may differ significantly from those stated in this press release, and the company has no obligation to update such statements. There are numerous risks and uncertainties that may have a negative impact on the company's performance, including those identified in the company's 10-Q filing for the fiscal year ending July 31, 2026 (see pages 33 to 34 for a summary of relevant risks), as well as in subsequent filings submitted to the U.S. Securities and Exchange Commission, which can be viewed at sec.gov.